These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 37324258

  • 1. Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease.
    Drożdż M, Moczulska A, Rudziński A, Drożdż D.
    Front Endocrinol (Lausanne); 2023; 14():1215527. PubMed ID: 37324258
    [Abstract] [Full Text] [Related]

  • 2. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183
    [Abstract] [Full Text] [Related]

  • 4. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789
    [Abstract] [Full Text] [Related]

  • 5. Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.
    Jaques DA, Müller H, Martinez C, De Seigneux S, Martin PY, Ponte B, Saudan P.
    Blood Press Monit; 2018 Oct 06; 23(5):244-252. PubMed ID: 29958233
    [Abstract] [Full Text] [Related]

  • 6. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
    Drożdż T, Kwinta P, Kordon Z, Sztefko K, Rudziński A, Zachwieja K, Miklaszewska M, Czarnecka D, Drożdż D.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):171-176. PubMed ID: 29775443
    [Abstract] [Full Text] [Related]

  • 7. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H, Choi HJ, Kang HG, Ha IS, Cheong HI, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS.
    Kidney Blood Press Res; 2017 Apr 23; 42(3):406-415. PubMed ID: 28689198
    [Abstract] [Full Text] [Related]

  • 8. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM, Roem J, Cox C, Schneider MF, Wilson AC, Furth SL, Warady BA, Mitsnefes M.
    Am J Kidney Dis; 2020 Aug 23; 76(2):166-173. PubMed ID: 32389356
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II, Arodiwe EB, Ijoma CK.
    Ethn Dis; 2006 Aug 23; 16(4):859-64. PubMed ID: 17061738
    [Abstract] [Full Text] [Related]

  • 10. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
    Fu X, Ren H, Xie J, Wang W, Li Y, Gao P, Chen N.
    JAMA Netw Open; 2022 May 02; 5(5):e2214460. PubMed ID: 35616936
    [Abstract] [Full Text] [Related]

  • 11. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007 May 02; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 12. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD, Portman RJ.
    Adv Chronic Kidney Dis; 2004 Apr 02; 11(2):143-61. PubMed ID: 15216486
    [Abstract] [Full Text] [Related]

  • 13. Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD.
    Lee J, McCulloch CE, Flynn JT, Samuels J, Warady BA, Furth SL, Seth D, Grimes BA, Mitsnefes MM, Ku E.
    Clin J Am Soc Nephrol; 2020 Apr 07; 15(4):493-500. PubMed ID: 32160993
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.
    Wen RW, Chen XQ, Zhu Y, Ke JT, Du Y, Wang C, Lou TQ.
    BMC Nephrol; 2020 Dec 11; 21(1):541. PubMed ID: 33308181
    [Abstract] [Full Text] [Related]

  • 15. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
    Wang CJ, Bao XR, Du GW, Wang Y, Chen K, Shen ML, Wang LZ.
    Int Urol Nephrol; 2014 Aug 11; 46(8):1609-17. PubMed ID: 24839054
    [Abstract] [Full Text] [Related]

  • 16. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Aug 11; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 17. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
    Kim JY, Lee Y, Kang HG, Ha IS, Cheong HI, Choi HJ, Han KH, Kim SH, Cho MH, Shin JI, Lee JH, Park YS, Cho H.
    BMC Nephrol; 2020 Dec 09; 21(1):533. PubMed ID: 33297989
    [Abstract] [Full Text] [Related]

  • 18. Nocturnal pulse rate correlated with ambulatory blood pressure and target organ damage in patients with chronic kidney disease.
    Zhang J, Wen R, Yin J, Zhu Y, Lin L, Ye Z, Peng H, Wang C, Lou T.
    J Clin Hypertens (Greenwich); 2019 Jan 09; 21(1):77-87. PubMed ID: 30597750
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of etiology and complications in children with stage 5 chronic kidney disease].
    Zhong C, Chen YL, Yu XX, Yang Q, Shi YQ, Tan LW, Wang AS, Wu DQ, Zhang GF, Yang HP, Li Q, Wang M.
    Zhonghua Er Ke Za Zhi; 2023 Dec 02; 61(12):1109-1117. PubMed ID: 38018048
    [Abstract] [Full Text] [Related]

  • 20. Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.
    Litwin M, Sladowska J, Syczewska M, Niemirska A, Daszkowska J, Antoniewicz J, Wierzbicka A, Wawer ZT.
    Pediatr Nephrol; 2008 May 02; 23(5):787-96. PubMed ID: 18253758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.